Literature DB >> 20655901

Pharmacological concentrations of biotin reduce serum triglycerides and the expression of lipogenic genes.

Elena Larrieta1, Fidel Velasco, Paz Vital, Teresita López-Aceves, María Luisa Lazo-de-la-Vega-Monroy, Alberto Rojas, Cristina Fernandez-Mejia.   

Abstract

Besides its role as a carboxylase prosthetic group, biotin regulates gene expression and has a wide repertoire of effects on systemic processes. Several studies have shown that pharmacological concentrations of biotin reduce hypertriglyceridemia. The molecular mechanisms by which pharmacological concentrations of biotin affect lipid metabolism are largely unknown. The present study analyzed the effects of pharmacological doses of biotin on triglyceridemia, insulin sensitivity and on mRNA expression of various lipogenic genes. Three-week-old male BALB/cAnN Hsd mice were fed a biotin-control or a biotin-supplemented diet (1.76 or 97.7mg of free biotin/kg diet, respectively) over a period of eight weeks. Serum triglyceride concentrations, insulin and glucose tolerance and mRNA abundance of various lipogenic genes were investigated. The biotin-supplemented group showed 35% less serum triglycerides than control mice. In the liver, we found a significant (P<0.05) reduction of mRNA levels of SREBP1-c, glucose transporter-2, phosphofructokinase-1, pyruvate kinase, acetyl-CoA carboxylase and fatty acid synthase, while glucose-6-phosphate dehydrogenase expression increased. No changes in glucokinase, stearoyl-CoA desaturase-1, FoxO1 or PPAR-gamma expression were observed. In adipose tissue, we found a decreased expression of SREBP1c, glucose-6-phosphate deshydrogenase, acetyl-CoA carboxylase, fatty acid synthase, stearoyl-CoA desaturase-1, phosphofructokinase-1 and PPAR-gamma, but no changes in FoxO1 expression. Moreover, the group fed a biotin-supplemented diet showed a significant decrease in adipose tissue weight. No differences in insulin sensitivity or serum insulin concentrations were observed between groups. Our results indicate that pharmacological concentrations of biotin decrease serum tryglyceride concentrations and lipogenic gene expression in liver and adipose tissues. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655901     DOI: 10.1016/j.ejphar.2010.07.009

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Survey of the effect of biotin on glycemic control and plasma lipid concentrations in type 1 diabetic patients in kermanshah in iran (2008-2009).

Authors:  Mitra Hemmati; Homa Babaei; Mohammadreza Abdolsalehei
Journal:  Oman Med J       Date:  2013-05

2.  Biotin-dependent functions in adiposity: a study of monozygotic twin pairs.

Authors:  E Järvinen; K Ismail; M Muniandy; L H Bogl; S Heinonen; M Tummers; S Miettinen; J Kaprio; A Rissanen; M Ollikainen; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2015-11-25       Impact factor: 5.095

3.  Dietary Biotin Supplementation Modifies Hepatic Morphology without Changes in Liver Toxicity Markers.

Authors:  Leticia Riverón-Negrete; Gloria Sicilia-Argumedo; Carolina Álvarez-Delgado; Elvia Coballase-Urrutia; Jonathan Alcántar-Fernández; Cristina Fernandez-Mejia
Journal:  Biomed Res Int       Date:  2016-12-25       Impact factor: 3.411

4.  Association between the index of nutritional quality and lipid profile in adult women.

Authors:  Saheb Abbas Torki; Effat Bahadori; Soheila Shekari; Soroor Fathi; Maryam Gholamalizadeh; Naeemeh Hasanpour Ardekanizadeh; Bahareh Aminnezhad; Mina Ahmadzadeh; Mahtab Sotoudeh; Fatemeh Shafie; Samira Rastgoo; Farhad Vahid; Saeid Doaei
Journal:  Endocrinol Diabetes Metab       Date:  2022-07-20

5.  Biotin starvation causes mitochondrial protein hyperacetylation and partial rescue by the SIRT3-like deacetylase Hst4p.

Authors:  Christian T Madsen; Kathrine B Sylvestersen; Clifford Young; Sara C Larsen; Jon W Poulsen; Marianne A Andersen; Eva A Palmqvist; Martin Hey-Mogensen; Per B Jensen; Jonas T Treebak; Michael Lisby; Michael L Nielsen
Journal:  Nat Commun       Date:  2015-07-09       Impact factor: 14.919

6.  Modulation of the rat hepatic cytochrome P4501A subfamily using biotin supplementation.

Authors:  M D Ronquillo-Sánchez; R Camacho-Carranza; C Fernandez-Mejia; S Hernández-Ojeda; M Elinos-Baez; J J Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.